✦ LIBER ✦

Randomized, double-blind, placebo-controlled, short-term trial of ropinirole in restless legs syndrome

✍ Scribed by D.L. Bliwise; A. Freeman; C.D. Ingram; D.B. Rye; S. Chakravorty; R.L. Watts

Book ID: 116883742
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 137 KB
Volume: 6
Category: Article
ISSN: 1389-9457
DOI: 10.1016/j.sleep.2004.12.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled trial of intravenous iron sucrose in restless legs syndrome

✍ Christopher J. Earley; Alena Horská; Mona A. Mohamed; Peter B. Barker; John L. B 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 114 KB

A double-blind randomized crossover tria

A double-blind randomized crossover trial of bromocriptine and placebo in restless legs syndrome

✍ Dr. Arthur S. Walters; Wayne A. Hening; Neil Kavey; Sudhansu Chokroverty; Steve 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 419 KB 👁 2 views

A double-blind randomized crossover study of 7.5 mg bromocriptine at bedtime versus placebo was conducted in 30-day phases (with a 2-week washout period between phases) in 6 patients with idiopathic restless legs syndrome. Five patients experienced partial subjective improvement in restlessness and

Ropinirole is effective in the long-term

Ropinirole is effective in the long-term management of restless legs syndrome: A randomized controlled trial

✍ Jacques Montplaisir; Jeff Karrasch; Jean Haan; Dieter Volc 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 302 KB 👁 1 views

## Abstract The objective of this study was to investigate the long‐term efficacy of ropinirole in patients with restless legs syndrome (RLS) and to assess the potential for relapse after the discontinuation of active treatment. Patients with primary RLS (n = 202) received single‐blind ropinirole f

Rotigotine improves restless legs syndro

Rotigotine improves restless legs syndrome: A 6-month randomized, double-blind, placebo-controlled trial in the United States

✍ Wayne A. Hening; Richard P. Allen; William G. Ondo; Arthur S. Walters; John W. W 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 229 KB 👁 1 views

## Abstract This randomized, double‐blinded, placebo‐controlled trial (NCT00135993) assessed efficacy and safety of the dopamine agonist rotigotine in the treatment of idiopathic restless legs syndrome (RLS) over a 6‐month maintenance period. A total of 505 eligible participants with moderate to se

Ropinirole is effective in the treatment

Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: A 12-week, double-blind, randomized, parallel-group, placebo-controlled study

✍ Arthur S. Walters; William G. Ondo; Tilman Dreykluft; Ron Grunstein; Daniel Lee; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 181 KB 👁 1 views

## Abstract Restless legs syndrome (RLS) is a neurological condition with significant impact on sleep and quality of life (QoL). This double‐blind, randomized, 12‐week, multinational study compared the efficacy and safety of ropinirole and placebo in RLS. In total, 267 outpatients with moderate‐to‐

Efficacy of rotigotine transdermal syste

Efficacy of rotigotine transdermal system in severe restless legs syndrome: A randomized, double-blind, placebo-controlled, six-week dose-finding trial in Europe

✍ Wolfgang H. Oertel; Heike Benes; Diego Garcia-Borreguero; Peter Geisler; Birgit 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 392 KB